ライフサイエンスコーパス: TOF-MS

1 asers to increase sample throughput of axial TOF MS instruments, obtaining a high-resolution image st

2 horesis/time-of-flight mass spectrometry (CE/TOF-MS) methodology for these labeled glycans, which com

3 icability of two different platforms (LC-ESI-TOF MS and LC-ESI-IT MS) as powerful tools for the chara

4 lutive chromatographic method coupled to ESI-TOF MS (for initial characterisation purposes) and coupl

5 n time-of-flight mass spectrometry (HPLC-ESI-TOF-MS) method has been applied for the separation, iden

6 arp of this fruit was studied using HPLC/ESI-TOF-MS.

7 ray time-of-flight mass spectrometry (LC-ESI-TOF-MS) has been applied to screen bioactive metabolites

8 the basis of the additional dimension of ESI-TOF-MS.

9 zation time-of-flight mass spectrometry (ESI-TOF-MS) to derive the reaction mechanism and to obtain t

10 zation time-of-flight mass spectrometry (ESI-TOF-MS), thereby demonstrating the influence of differen

11 zation time-of flight mass spectrometry (ESI-TOF-MS).

12 ography-time-of-flight mass spectrometry (GC-TOF-MS) based metabolomics combined with partial least s

13 TD-GC-TOF-MS was used and a technique for the extraction of VO

14 trometry (GC-MS) and High Resolution GC x GC-TOF-MS (GC x GC HRT-4D).

15 th time-of-flight mass spectrometry (GC x GC-TOF-MS) measurements, each with an associated match fact

16 hy-time-of-flight mass spectrometry (GC x GC-TOF-MS), and their identity were confirmed by comparison

17 hy time-of-flight mass spectrometry (GC x GC-TOF-MS).

18 ography/time-of-flight mass spectrometry (GC/TOF-MS), here used to examine the S. cerevisiae metabolo

19 sample processing of data acquired by GCxGC-TOF MS for the identification of potentially novel persi

20 aphy time-of-flight mass spectrometry (GCxGC-TOF MS) is considered as a powerful analytical platform

21 with time-of-flight mass spectrometry (GCxGC-TOF MS).

22 I) was evaluated as the ion source for GCxGC-TOF-MS measurements.

23 or Italian sparkling wines, by HS-SPME-GCxGC-TOF-MS and multivariate analysis.

24 dentification power of PI coupled with GCxGC-TOF-MS is the first report covering volatiles to low-vol

25 aselines, and GC(2)MS is able to align GCxGC/TOF-MS data sets acquired under different experimental c

26 However, GCxGC/TOF-MS data processing is currently limited to vendor so

27 the application of recent advances in GCxGC/TOF-MS, especially for metabolomics studies.

28 zed by a nontargeted approach based on GCxGC/TOF-MS.

29 aphy time-of-flight mass spectrometry (GCxGC/TOF-MS) is superior for chromatographic separation and p

30 GC(2)MS treats GCxGC/TOF-MS data as pictures and clusters the pixels as blobs

31 GC(2)MS then aligns the blobs of two GCxGC/TOF-MS data sets according to their distance and similar

32 ormance of GC(2)MS was evaluated using GCxGC/TOF-MS data sets of Angelica sinensis compounds acquired

33 An FM GC x GC-HR TOF MS method was developed for the untargeted and targe

34 olution time-of-flight mass spectrometer (HR TOF MS), under the challenging conditions of a flow-modu

35 The HR TOF MS instrument was operated at a spectral generation

36 yed for the analysis of crude oils using IMS-TOF MS.

37 time-of-flight mass spectrometry (LAESI-IMS-TOF-MS) was used for the analysis of synthetic polymers

38 rap-time of flight mass spectrometry (ESI-IT-TOF-MS).

39 on-trap time-of-flight mass spectrometer (IT-TOF-MS) for the separation and identification of constit

40 a time-of-flight mass spectrometer (UPLC-IT-TOF-MS) that allowed the characterization of the toxin p

41 0.27 mg/g of lyophilized coral using UPLC-IT-TOF-MS.

42 4-ylium derivatives were identified using LC-TOF MS analysis.

43 e-of-flight mass spectrometric detection (LC-TOF-MS) and LC with tandem MS (MS/MS) detection have bee

44 A), and time of flight mass spectrometry (LC-TOF-MS) analysis.

45 hat accurately detects the pure ions of a LC/TOF-MS profile to extract pure ion chromatograms and det

46 ography/time-of-flight mass spectrometry (LC/TOF-MS) chromatograms of 228 plasma samples and 23 poole

47 ography/time-of-flight mass spectrometry (LC/TOF-MS) ion signals in a complex biological sample remai

48 /+) degradation series in the respective LDI-TOF MS studies.

49 zation time-of-flight mass spectrometry (LDI-TOF MS) studies of the crystalline samples show intense

50 nning mirror, a laboratory-built axial MALDI TOF MS instrument utilizing a 4-kHz UV laser recorded a

51 tion time-of-flight mass spectrometry (MALDI TOF MS) imaging of surfaces and tissues is a rapidly evo

52 An in vitro MALDI TOF MS-based activity assay that detects ricin mediated

53 MALDI-TOF MS analysis of the reaction products demonstrated th

54 MALDI-TOF MS analysis of the suspension after density-based se

55 MALDI-TOF MS demonstrated 80.1% (117/146) and 87.7% (128/146)

56 MALDI-TOF MS has the potential to expedite mold identification

57 MALDI-TOF MS identified 93.8% of the mycobacteria isolates acc

58 MALDI-TOF MS is a valuable tool for the identification of thes

59 MALDI-TOF MS not only represents an innovative technology for

60 MALDI-TOF MS offers a rapid, inexpensive method for identifica

61 MALDI-TOF MS plus AMS intervention significantly reduced the o

62 MALDI-TOF MS significantly improved TAT for organism ID.

63 MALDI-TOF MS spectra of five F. nucleatum subspecies (animalis

64 MALDI-TOF MS was effective for the identification of mycobacte

65 MALDI-TOF MS was performed to characterize structural variatio

66 MALDI-TOF MS with the modified SARAMIS database further correc

67 grees C using a spectrophotometer) and MALDI-TOF MS (both the standard result output and by visual sp

68 standardized culture, extraction, and MALDI-TOF MS analysis, isolates were identified using score cu

69 value (NPV) of MALDI-TOF MS alone and MALDI-TOF MS coupled with UA were 86.6% versus 93.4% (chi(2) =

70 cation (CONV), (ii) manual plating and MALDI-TOF MS identification (MALDI), (iii) MALDI-TOF MS identi

71 Chemical cross-linking and MALDI-TOF MS mapped these same regions to the PhuS:HemO protei

72 ity and that the combination of UA and MALDI-TOF MS provided an accurate and rapid detection and iden

73 (1)H and (13)C NMR spectroscopy and MALDI-TOF MS showed a rigorously alternating sequence.

74 yeast were analyzed with QuickFISH and MALDI-TOF MS.

75 ant factors that must be considered as MALDI-TOF MS moves into applications beyond microbial identifi

76 fication by use of the Bruker Biotyper MALDI-TOF MS system, including density of organism spotting on

77 s study evaluated the Bruker Biotyper (MALDI-TOF MS) system for the identification of clinically rele

78 (0.9%) isolates were misidentified by MALDI-TOF MS (including Aspergillus amoenus [n = 2] and Asperg

79 the substitution has been validated by MALDI-TOF MS analysis of the functionalized precursors and FT-

80 Identification by MALDI-TOF MS potentially reduces the turnaround time and cost,

81 y testing of the samples identified by MALDI-TOF MS produced an overall categorical agreement of 99.2

82 ISA and VSSA isolates are separable by MALDI-TOF MS with SVM analysis.

83 ng bioconjugates were characterized by MALDI-TOF MS, differential scanning calorimetry (DSC), fluores

84 for both DP8 and DP9 were confirmed by MALDI-TOF MS, including two of high confidence, calreticulin a

85 idin-3,5-O-diglycoside was verified by MALDI-TOF MS.

86 er species identification performed by MALDI-TOF MS.

87 SDS-PAGE and protein identification by MALDI-TOF MS.

88 mass spectrometry on tissue samples by MALDI-TOF MS.

89 ISA, 21 hVISA, and 38 VSSA isolates by MALDI-TOF MS.

90 Here we report combined MALDI-TOF MS experiments, NMR analyses and quantum mechanical/

91 This minireview explores MALDI-TOF MS-based typing, which has already been performed on

92 h 31, 2014, were directly compared for MALDI-TOF MS and conventional methodologies.

93 terial and yeast isolates prepared for MALDI-TOF MS identification can be repeatedly analyzed without

94 We conclude that guidelines for MALDI-TOF MS-based typing can be developed along the same line

95 I-TOF MS identification (MALDI), (iii) MALDI-TOF MS identification and early phase implementation of

96 elevant Nocardia spp. and to implement MALDI-TOF MS libraries developed by single laboratories across

97 ed characteristic isotopic patterns in MALDI-TOF MS, and both a fragmentation product y1 ion correspo

98 implementation of TLA (TLA1), and (iv) MALDI-TOF MS identification and late phase implementation of T

99 ty of the Bruker Biotyper and Vitek MS MALDI-TOF MS systems and their in vitro diagnostic (IVD), rese

100 red, demonstrate the value of this new MALDI-TOF MS method as an analytical tool for the identificati

101 s have been characterized by (1)H NMR, MALDI-TOF MS, steady-state absorption and emission spectroscop

102 dia isolates, and NIH and OSU Nocardia MALDI-TOF MS libraries were distributed to three centers.

103 supplementation of the Bruker Nocardia MALDI-TOF MS library with both the OSU and NIH libraries incre

104 and negative predictive value (NPV) of MALDI-TOF MS alone and MALDI-TOF MS coupled with UA were 86.6%

105 is study was to evaluate the impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time

106 Use of MALDI-TOF MS and TLA individually and together results in sign

107 aluated the capacity of combination of MALDI-TOF MS and urine analysis (UA) for direct detection and

108 Our work highlights applications of MALDI-TOF MS beyond identification, focusing on mycobacterial

109 The use of MALDI-TOF MS equated to a net savings of $69,108.61, or 87.8%,

110 highlights the superior performance of MALDI-TOF MS for bacterial identification.

111 ee sites, while specificity and NPV of MALDI-TOF MS for males were significantly higher than those fo

112 data describing the reproducibility of MALDI-TOF MS for microbial identification are scarce.

113 s review discusses the various uses of MALDI-TOF MS for the identification and susceptibility testing

114 his work, we report the specificity of MALDI-TOF MS for the identification of 162 Mycobacterium speci

115 ecent literature describing the use of MALDI-TOF MS for the routine identification of a variety of ye

116 United States demonstrating the use of MALDI-TOF MS to facilitate the clinical diagnosis in patients

117 in the databases and in the ability of MALDI-TOF MS to rapidly identify slowly growing mycobacteria a

118 specificity study, the performance of MALDI-TOF MS was directly compared with that of 16S rRNA gene

119 on of Gram-positive bacteria by use of MALDI-TOF MS.

120 peptides at other times of processing, MALDI-TOF MS was also employed as a fast and easier technique.

121 tion-time of flight mass spectrometry (MALDI-TOF MS) (e.g., Streptococcus oralis).

122 tion-time-of-flight mass spectrometry (MALDI-TOF MS) after enzymatic digestion of the polysaccharide

123 tion-time of flight mass spectrometry (MALDI-TOF MS) and 16S rRNA gene sequencing.

124 tion-time of flight mass spectrometry (MALDI-TOF MS) and a fucK diagnostic assay.

125 tion-time of flight mass spectrometry (MALDI-TOF MS) and BD Kiestra total laboratory automation (TLA)

126 tion-time of flight mass spectrometry (MALDI-TOF MS) and evaluated the capacity of combination of MAL

127 tion-time-of flight mass spectrometry (MALDI-TOF MS) assay was developed to detect these and six prev

128 tion-time of flight mass spectrometry (MALDI-TOF MS) can be used as a method for the rapid identifica

129 tion-time of flight mass spectrometry (MALDI-TOF MS) decreases the time to organism identification an

130 tion-time of flight mass spectrometry (MALDI-TOF MS) directly from positive blood cultures using prew

131 tion time-of-flight mass spectrometry (MALDI-TOF MS) experiments.

132 on - time-of-flight mass spectrometry (MALDI-TOF MS) fingerprinting of proteins was developed.

133 tion-time of flight mass spectrometry (MALDI-TOF MS) for group B streptococcus (GBS) identification,

134 tion-time of flight mass spectrometry (MALDI-TOF MS) for identification of Fusobacterium nucleatum su

135 tion-time of flight mass spectrometry (MALDI-TOF MS) for rapid organism identification and dedicating

136 tion-time of flight mass spectrometry (MALDI-TOF MS) for the identification of bacteria and yeasts is

137 tion time of flight mass spectrometry (MALDI-TOF MS) for the identification of Exophiala species.

138 tion-time of flight mass spectrometry (MALDI-TOF MS) for the identification of NTM isolated on RGM me

139 tion-time of flight mass spectrometry (MALDI-TOF MS) has become the standard for routine bacterial sp

140 tion-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid and accurate method for i

141 tion-time of flight mass spectrometry (MALDI-TOF MS) has recently been described as a fast and inexpe

142 tion-time of flight mass spectrometry (MALDI-TOF MS) has recently been reported to be a reliable and

143 tion-time of flight mass spectrometry (MALDI-TOF MS) has reduced the time to identification of cultur

144 tion-time of flight mass spectrometry (MALDI-TOF MS) has revolutionized clinical microbiology for iso

145 tion-time of flight mass spectrometry (MALDI-TOF MS) identification, and score interpretation, using

146 tion-time of flight mass spectrometry (MALDI-TOF MS) identified Staphylococcus lugdunensis to be a mo

147 tion-time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology has revolutionized spec

148 tion-time of flight mass spectrometry (MALDI-TOF MS) in conjunction with active antimicrobial steward

149 tion time of flight mass spectrometry (MALDI-TOF MS) in the identification of Haemophilus, Aggregatib

150 tion-time of flight mass spectrometry (MALDI-TOF MS) is a powerful tool for the rapid and highly accu

151 tion time of flight mass spectrometry (MALDI-TOF MS) is a rapid and accurate method of identifying mi

152 tion time-of-flight mass spectrometry (MALDI-TOF MS) is currently changing the clinical routine for i

153 tion time-of-flight mass spectrometry (MALDI-TOF MS) is frequently used for the characterization of c

154 tion time-of-flight mass spectrometry (MALDI-TOF MS) platforms in the medical microbiological practic

155 tion-time of flight mass spectrometry (MALDI-TOF MS) sample preparation methods, including the direct

156 tion-time of flight mass spectrometry (MALDI-TOF MS) system.

157 sorption/ionization mass spectrometry (MALDI-TOF MS) that allows quantification of pure or mixed dete

158 tion-time of flight mass spectrometry (MALDI-TOF MS) to detect pKpQIL_p019 (p019)-an approximately 11

159 tion-time of flight mass spectrometry (MALDI-TOF MS) was used to confirm selectivity of imprints.

160 tion-time of flight mass spectrometry (MALDI-TOF MS) with Sepsityper processing (Bruker Daltonics, Bi

161 tion time-of-flight mass spectrometry (MALDI-TOF MS), and nucleic acid aptamers.

162 tion-time of flight mass spectrometry (MALDI-TOF MS), sequencing of eight genes in the GPL locus, and

163 tion-time of flight mass spectrometry (MALDI-TOF MS), suspicious isolates are now routinely identifie

164 tion time-of-flight mass spectrometry (MALDI-TOF MS)-based assay was developed that could directly fo

165 tion-time of flight mass spectrometry (MALDI-TOF MS)-based identifications of the flown and stationar

166 tion-time-of-flight mass spectrometry (MALDI-TOF MS)-proteomics.

167 tion-time of flight mass spectrometry (MALDI-TOF MS).

168 tion-time of flight mass spectrometry (MALDI-TOF MS).

169 tion-time-of-flight mass spectrometry (MALDI-TOF MS).

170 tion-time of flight mass spectrometry (MALDI-TOF MS).

171 tion-time of flight mass spectrometry (MALDI-TOF MS).

172 tion-time of flight mass spectrometry (MALDI-TOF MS).

173 tion-time of flight mass spectrometry (MALDI-TOF MS).

174 me-of-flight tandem mass spectrometry (MALDI-TOF MS/MS), we now reveal that actually up to five fucos

175 tion time-of-flight mass spectrometry (MALDI-TOF MS; 14 SNPs) in at least 1303 Caucasian children (65

176 In summary, MALDI-TOF MS allows the rapid and accurate identification of a

177 MS intervention is more impactful than MALDI-TOF MS alone.

178 ynamic range and higher precision than MALDI-TOF MS, while still generating results in a similar time

179 In this study, we show that MALDI-TOF MS-based microbial identification is highly reproduc

180 With the MALDI-TOF MS assay, glutamine-containing peptides derived from

181 The results show the MALDI-TOF MS LBA platforms provide limits of quantitation to ~

182 r aerobic actinomycetes using both the MALDI-TOF MS manufacturer's supplied database(s) and a custom

183 142,532.69, versus $68,886.51 with the MALDI-TOF MS method, resulting in a laboratory savings of $73,

184 Plasmid identification using this MALDI-TOF MS method was accomplished in as little as 10 min fr

185 AMS intervention included: real-time MALDI-TOF MS pharmacist notification and prospective AMS provi

186 cobacteria require extraction prior to MALDI-TOF MS analysis, previously published protocols have bee

187 Desalting is not needed prior to MALDI-TOF MS.

188 Here we compared two MALDI-TOF MS instrumentation platforms and three databases: Br

189 ng to pre-TLA and post-TLA, both using MALDI-TOF MS for organism identification.

190 l microbiology laboratories to utilize MALDI-TOF MS for the rapid identification of clinically releva

191 he impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time, pharmacist-driven, antim

192 positive blood cultures identified via MALDI-TOF MS combined with prospective AMS intervention compar

193 ost of performing the bioMerieux Vitek MALDI-TOF MS with conventional microbiological methods to dete

194 gainst all Exophiala isolates in vitro MALDI-TOF MS successfully distinguished all 18 species and ide

195 ptibility testing might be useful when MALDI-TOF MS results in an organism identification, and it mig

196 al outcomes, rapid identification with MALDI-TOF MS combined with real-time AMS intervention is more

197 tion compared to a control cohort with MALDI-TOF MS identification without AMS intervention.

198 n an off-line combination of CIEF with MALDI-TOF MS was employed for rapid and reliable identificatio

199 MALDI-TOF-MS analysis of N-linked glycans demonstrated reduced

200 MALDI-TOF-MS analysis showed that the crude reaction products

201 MALDI-TOF-MS shows excellent potential for sensitive and rapid

202 chniques such as RP-HPLC-UV, GFAAS and MALDI-TOF-MS allowed the identification of several proteins bo

203 thod for sialic acid stabilization and MALDI-TOF-MS analysis, to allow direct modification of impure

204 lotron resonance mass spectrometry and MALDI-TOF-MS).

205 applied microchip electrophoresis and MALDI-TOF-MS-based glycomic procedures to 20 control serum sam

206 nd E nterobacter spp. were analyzed by MALDI-TOF-MS in negative ion mode to obtain glycolipid mass sp

207 solid phase extraction and analyzed by MALDI-TOF-MS in reflectron positive mode with 2,5-dihydroxyben

208 Biotyping by MALDI-TOF-MS will prove effective in situations wherein precis

209 In contrast, MALDI-TOF-MS tracked as much (1)O2-induced RNA damage as RT-qP

210 hed an expeditious method that couples MALDI-TOF-MS with a simple dilution method to quantify curcumi

211 onisation properties and resolution in MALDI-TOF-MS, these phosphopeptides were identified as suitabl

212 y of tissue samples are, for instance, MALDI-TOF-MS and Raman microscopic imaging.

213 -assisted laser desorption/ionization (MALDI-TOF-MS) for determination of Cu, Fe, Mn and Zn and ident

214 B and 1.2 x 10(5) J/m(2) UVA), neither MALDI-TOF-MS nor RT-qPCR detected significant decreases in the

215 5 h and automated data acquisition on MALDI-TOF-MS took on average less than 1 min per sample.

216 chip technology (24 polymorphisms) or MALDI-TOF-MS (40 polymorphisms) in at least 1303 German childr

217 Following UV254 exposure, quantitative MALDI-TOF-MS detected significantly more RNA modifications tha

218 tion method to allow subclass-specific MALDI-TOF-MS analysis of tryptic IgG glycopeptides.

219 tion time-of-flight mass spectrometry (MALDI-TOF-MS) analysis of high abundance proteins is gaining p

220 tion time-of-flight mass spectrometry (MALDI-TOF-MS) and tandem mass spectrometry (MS(2)).

221 tion Time of Flight Mass Spectrometry (MALDI-TOF-MS) biotyping to deliver rapid and accurate strain s

222 with time-of-flight mass spectrometry (MALDI-TOF-MS) has been used to analyse various molecules (incl

223 tion time-of-flight mass spectrometry (MALDI-TOF-MS) has successfully been used for the analysis of h

224 tion time-of-flight mass spectrometry (MALDI-TOF-MS) is a valuable tool for glycan characterization a

225 tion-time-of-flight-mass spectrometry (MALDI-TOF-MS) is presented.

226 tion time-of-flight mass spectrometry (MALDI-TOF-MS) method and corresponding mathematic matrix to de

227 tion time-of-flight mass spectrometry (MALDI-TOF-MS) to study deamidation in wool textiles, we identi

228 tion time-of-flight mass spectrometry (MALDI-TOF-MS), and molecular simulation results.

229 tion time-of-flight mass spectrometry (MALDI-TOF-MS).

230 - time of flight - mass spectrometry (MALDI-TOF-MS).

231 ation with minimal side reactions: the MALDI-TOF-MS profiles obtained were in good agreement with hyd

232 cylglycerol) in complex mixtures using MALDI-TOF-MS with fractional factorial design (FFD) and Pareto

233 attern of molecular distribution using MALDI-TOF-MS.

234 y RNA pulldown experiments followed by MALDI/TOF-MS analysis, we identified heterogeneous nuclear rib

235 s performed using 2-D-DIGE followed by MALDI/TOF-MS.

236 tireflection time-of-flight mass spectra (MR-TOF MS).

237 for wide m/z range applications, whereas MR-TOF MS can provide advantages in a "zoom-in" mode in whi

238 prising both conventional time-of-flight MS (TOF-MS) and nano-electromechanical systems-based MS (NEM

239 time-of-flight mass spectrometry (IR-MALDI-o-TOF MS) in combination with collision-induced dissociati

240 the high resolution, accuracy, and speed of TOF-MS for eased glycan identification.

241 In this paper, we present results of a PI-TOF-MS study at the Advanced Light Source at Lawrence Be

242 ble to those with other synchrotron-based PI-TOF-MS reactors, and it is anticipated that this high pr

243 S research to include synchrotron sourced PI-TOF-MS required a radical reconception of the shock tube

244 ization time-of-flight mass spectrometry (PI-TOF-MS) is an important technique in combustion chemistr

245 action-time-of-flight-mass spectrometer (PTR-TOF-MS) were compared to BEFs reported in previous studi

246 action time-of-flight mass spectrometry (PTR-TOF-MS).

247 ncrease in pressure compared to standard PTR-TOF-MS.

248 is was performed using hybrid quadrupole (Q) TOF MS with an atmospheric pressure chemical ionization

249 cation and multivariate analysis to UHPLC-(Q)TOF MS data acquired in both, positive and negative ioni

250 pole-time-of-flight mass spectrometry (ESI-Q-TOF MS).

251 upole time-of-flight mass spectrometry (LC-Q-TOF MS) is described.

252 adrupole time-of-flight mass spectrometry (Q-TOF MS).

253 le time-of-flight mass spectrometry (UHPLC-Q-TOF MS) platform.

254 -of-flight mass spectrometry (nanoUPLC-ESI-q-TOF-MS(E)).

255 ocol starts from untargeted metabolomic LC-Q-TOF-MS data that have been analyzed with the bioinformat

256 upole time-of-flight mass spectrometry (LC-Q-TOF-MS) was utilized to acquire metabolic profiles of mu

257 upole time-of-flight mass spectrometry (LC-Q-TOF-MS), hundreds to thousands of peaks with a unique m/

258 upole time-of-flight mass spectrometry (LC-Q-TOF-MS)-based global metabolomics analysis.

259 aphy-high-resolution mass spectrometry (LC-Q-TOF-MS).

260 e was possible using either LC/MS-MS or LC/Q-TOF-MS under positive ionization.

261 upole time-of-flight mass spectrometry (LC/Q-TOF-MS) and triple quadrupole mass spectrometry (LC/MS-M

262 drupole time-of-flight mass spectrometers (Q-TOF-MS).

263 adrupole-time-of-flight mass spectrometry (Q-TOF-MS).

264 ttle was investigated by FTICR-MS and UPLC-Q-TOF-MS.

265 time of flight-mass spectrometry (UPLC-PDA-Q/TOF-MS) method.

266 of the OxPLs a recently introduced MALDI-QIT-TOF-MS/MS platform was employed and cross-validated by L

267 tored by UV-Vis spectroscopy and LC-ESI-(Qq)-TOF-MS-DAD, enabling the identification of some intermed

268 PD studies that the sensitivity of the REMPI-TOF-MS is comparable to commercial EI-Q-MS solutions and

269 le quadrupole MS and an ultrahigh resolution TOF-MS.

270 al rituximab sample shows that online sLCxLC-TOF-MS can be used to rapidly characterize mAb samples,

271 lities for time-of-flight mass spectrometer (TOF MS) IMS detection and mass analysis.

272 med with a time-of-flight mass spectrometer (TOF-MS) to allow for a comprehensive evaluation of the o

273 ionization time-of-flight mass spectrometry (TOF-MS) allows the detection of thousands of compounds.

274 apply LIAD time-of-flight mass spectrometry (TOF-MS) to the natural biochromophores chlorophyll, hemi

275 nalysis by time-of-flight mass spectrometry (TOF-MS).

276 GCxGC) and Time-Of-Flight mass spectrometry (TOF-MS).

277 ctrometry with NO(+) as the reagent ion (SRI-TOF-MS (NO(+))) was applied for near real-time monitorin

278 ubstantial increase in the throughput of the TOF MS-based tissue imaging can be achieved by incorpora

279 electrospray ionization (ESI) source to the TOF MS analyzer by means of a linear SLIM, demonstrating

280 gh sensitivity and high mass accuracy of the TOF-MS revealed the presence of more than 70 glycans.

281 imal plasmas were identified using MALDI-TOF-TOF MS.

282 issue sections was performed using MALDI-TOF/TOF MS in both negative and positive ionization modes af

283 time-of-flight mass spectrometry (MALDI-TOF/TOF MS) were used to assess the different protein expres

284 f flight tandem mass spectrometry (MALDI-TOF/TOF MS).

285 by fragmentation experiments using MALDI-TOF/TOF MS.

286 /time-of-flight mass spectrometry (MALDI-TOF/TOF-MS) for sequential identification of the peptide.

287 MR and DI-LC-MS/MS) and proteomic (MALDI-TOF/TOF-MS) platforms.

288 /time-of-flight mass spectrometry (MALDI-TOF/TOF-MS).

289 Extending the benefits of shock tube/TOF-MS research to include synchrotron sourced PI-TOF-MS

290 paper, the potential of Synapt G2-S (Q-TWIM-TOF MS) has been investigated for sensitive and specific

291 re studied, using FT-MIR, (1)H-NMR and UHPLC-TOF-MS.

292 combined metabolomic approach based on UHPLC-TOF-MS profiling and (1)H NMR fingerprinting to highligh

293 Quantitation by UHPLC/TOF-MS is accomplished by measuring the accurate mass of

294 aphy/time-of-flight mass spectrometry (UHPLC/TOF-MS), was used for the analysis of 60 pesticides in v

295 statically removed from the beam, and unlike TOF-MS, NEMS-MS can still measure masses.

296 raphy time-of-flight mass spectrometry (UPLC TOF-MS), Fourier transform ion cyclotron resonance (FT-I

297 Despite its lower resolution, UPLC-TOF MS was shown to offer a comparable level of reliabil

298 Here, we used UPLC/TOF-MS to survey the lipidome in SOD1(G86R) mice, a mode

299 raction down to the low picogram range using TOF-MS.

300 S(+) radical scavenging assay and LC-MS with TOF-MS for compositional analysis of the most potent ant